Abstract
Poliomyelitis remains a public health concern despite progress achieved through vaccination, due to the persistence of vaccine-derived polioviruses, particularly in areas with low immunization coverage. In the Democratic Republic of the Congo, although the country has been certified free of wild poliovirus, recurrent outbreaks continue to occur, especially in Kinshasa, as evidenced by acute flaccid paralysis (AFP) surveillance and environmental monitoring of wastewater. This descriptive and analytical cross-sectional study, conducted in Kinshasa from January to September 2025, aimed to assess the prevalence of polioviruses among children aged 0 to 5 years with AFP and in wastewater. A total of 186 samples were analyzed, including 93 stool samples from children originating from 13 health zones and 93 wastewater samples collected from 8 municipalities. Analyses were performed at the National Polio Reference Laboratory of the INRB and were based on viral isolation using cell culture (RD and L20B) followed by confirmation through real-time reverse transcription PCR (rRT-PCR). The prevalence of polioviruses among children with AFP was 11.8%, with 81.8% of positive cases occurring in incompletely vaccinated children; however, the association between infection and vaccination status was not statistically significant (p > 0.05). Environmental surveillance revealed an overall detection rate of 6.5%, with a predominance of vaccine-related strains (SL1, SL3, PV2/nOPV2), indicating silent environmental circulation of the virus. These findings demonstrate the persistent circulation of polioviruses in Kinshasa and highlight the need to strengthen immunization coverage as well as epidemiological and environmental surveillance in order to sustainably support polio eradication efforts in the Democratic Republic of the Congo.
References
1. Bessaud M. [New oral polio vaccine: A turning point for the global polio eradication initiative?]. Medecine tropicale et sante internationale. 2021;1(4).
2. John TJ, Dharmapalan D, Steinglass R, Hirschhorn N. The respiratory route of transmission of virulent polioviruses. Infectious Diseases. 2024;56(10):918-24.
3. Kalthan E, Gouandjika-Vasilache I, Mbailao R, Doté JW, Kossone MN, Gbangai M. [Discovery of Foci of Type-2 Poliovirus Derived from Oral Polio Vaccine in Central African Republic in 2019]. Medecine tropicale et sante internationale. 2021;1(2).
4. Seytre B. [Failure of poliomyelitis eradication campaign with oral vaccine: there's no vaccination without adherence]. Medecine tropicale et sante internationale. 2023;3(4).
5. Nsambu MN, Bazira L, Coulibaly T, Mbule A, Wilmet MD, Likwela JL. [Investigation and response to an outbreak of wild poliovirus in Kinshasa]. The Pan African medical journal. 2013;15:37.
6. OMS. Poliomyélite. 2025 2025. Report No.
7. OMS. Poliomyélite: principaux faits. 2025 Avril 2025. Report No.
8. unicef. Plus de 23 millions d’enfants de 0 à 59 mois ciblés au cours des Journées nationales de vaccination contre la poliomyélite en RDC. 2023 Juillet 2023. Report No.
9. Pozzetto B, Gagnaire J, Berthelot P, Bourlet T, Pillet S. [Viruses present in the environment: virological considerations and examples of their impact on human health]. Revue francophone des laboratoires : RFL. 2023;2023(550):33-43.
10. INRB. Formation régionale sur le séquençage de Poliovirus. 2023 Mai 2023. Report No.
11. Yelnik A, Levy-Bruhl D. Myélites aiguës flasques à entérovirus; des poliovirus aux entérovirus D68 et A71; épidémies et circulation dans les eaux usées. Bulletin de l'Académie Nationale de Médecine. 2024;208(9):1309-16.
12. Blaise YIJ, Cyriaque DC, Germain KK. Emergence of Vaccine-Derived Polioviruses (VDPVs) in Haut Katanga (DRC): Mapping of Risk Areas and Analysis of Eco-epidemiological Determinants, 2018-2023. Trends Gen Med. 2025;3(3):1-5.
13. Serge B, Mbondji E, Humphrey K, Janauschek L. Digitalisation des données de santé en Afrique: libérer le potentiel. 2024.
14. Jackson S, Chen ZJ. Genomic and expression plasticity of polyploidy. Current opinion in plant biology. 2010;13(2):153-9.
15. Kalbarczyk M, Skupiński S, Kosmulski M. Amino-functionalized silica as a component of heat-transfer fluids. Journal of Molecular Liquids. 2024;397:124195.
16. Pucchio AMR, Alabdulraheem A, Salvadori MI. [Not Available]. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2023;195(6):E247-e8.
17. Gbebangi-Manzemu D, Kampunzu VM, Vanzwa HM, Mumbere M, Bukaka GM, Likele BB, et al. Clinical profile of children under 5 years of age with rotavirus diarrhoea in a hospital setting in Kisangani, DRC, after the introduction of the rotavirus vaccine, a cross-sectional study. BMC pediatrics. 2023;23(1):193.
18. RAPPORT DPN. CAMEROUN.
19. Asghar H, Diop OM, Weldegebriel G, Malik F, Shetty S, El Bassioni L, et al. Environmental surveillance for polioviruses in the Global Polio Eradication Initiative. The Journal of infectious diseases. 2014;210 Suppl 1(Suppl 1):S294-303.
20. Bigi S, Ramette A, Barbani MT, Bieri A, Hoffmann A, Aebi C. Acute flaccid myelitis in Switzerland–association with enterovirus D68. Swiss Medical Weekly. 2023;153(2):40045-.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright (c) 2025 Lingamba et al.
